If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCaledonia Regulatory News (CLDN)

Share Price Information for Caledonia (CLDN)

Share Price is delayed by 15 minutes
Get Live Data
375.00    2.00 (0.54%)
Bid:
371.00
Ask:
374.00
Spread: 3.00 (0.809%)
Market Cap: £1.92b
CLDN Live PriceLast checked at - London Stock Exchange

Intraday Caledonia Share Chart

Director/PDMR Shareholding

27 Jun 2025 15:00

RNS Number : 8122O
Caledonia Investments PLC
27 June 2025
 

Caledonia Investments plc

 

Notification of transactions of persons discharging managerial responsibilities ("PDMR") or persons closely associated with them ("PCA")

 

Caledonia Investments plc ("Caledonia" or the "Company") has been notified pursuant to the requirements of the UK Market Abuse Regulation of the following transactions in its ordinary shares of 5p ("Shares") involving one of its directors, Jamie Cayzer-Colvin.

 

On 25 June 2025, 16,186 Shares, as noted in the table below, were transferred to Mr Cayzer-Colvin under the Caledonia Investments 2011 Performance Share Scheme ("2011 PSS") and the Caledonia Investments 2020 Deferred Bonus Plan ("DBP") at nil cost. The Shares were sourced from The Caledonia Investments plc Employee Share Trust ("EST"). 

 

Director

2011 PSS

DBP

J M B Cayzer-Colvin

11,520

4,666

 

On the same date, Mr Cayzer-Colvin sold:

 

· 7,630 Shares to the EST to meet the tax liability due; and

· 1,822 Shares to a member of the Cayzer family concert party.

 

Mr Cayzer-Colvin retained 6,734 Shares.

 

Following the above transactions, Mr Cayzer-Colvin's beneficial interests in the Company increased. 

 

Each of these transactions were conducted on-market in London. The Shares were sold to the EST and a member of the Cayzer family concert party at 3712.5p per Share.

 

Mr Cayzer-Colvin's total interests in Shares following the above transactions are as follows: 

 

Description

Number of Shares

Percentage of voting rights

Beneficial

250,969

0.477%

Non-beneficial

203,754

0.387%

Performance share scheme awards

98,559

0.187%

Deferred bonus plan awards

1,488

0.003%

 

Further information required by the UK Market Abuse Regulation in relation to these transactions is set out in the appendix below.

 

 

Enquiries:

Richard Webster

Company Secretary

Tel: +44 20 7802 8080

 

27 June 2025

 

APPENDIX

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

James Michael Beale Cayzer-Colvin

2

 

Reason for the notification

 

a)

 

Position/status

 

Executive Director

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Caledonia Investments plc

b)

 

LEI

 

2138002FX1MYCA5ZZH32

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

Ordinary 5p shares

 

 

GB0001639920

 

b)

 

Nature of the transaction

 

 

1. Exercise of Caledonia Investments 2011 Performance Share Scheme ("PSS") award

 

2. Exercise of Caledonia Investments 2020 Deferred Bonus Plan ("DBP") award

 

3. Partial sale of shares arising from PSS and DBP exercise to The Caledonia Investments plc Employee Share Trust ("EST")

 

4. Partial sale of shares to a member of the Cazyer family concert party

 

 

c)

 

 

Price(s) and volume(s)

 

1. Exercise of PSS award

 

 

2. Exercise of DBP award

 

 

3. Partial sale of shares arising from PSS award and DBP award to the EST

4. Partial sale of shares to a member of the Cazyer family concert party

 

Price(s)

 

Volume(s)

£nil

 

 

11,520

£nil

 

 

4,666

£37.125

 

 

7,630

£37.125

 

 

1,822

 

d)

 

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

 

 

N/A (single transaction)

e)

 

Date of the transaction

 

 

25 June 2025

f)

 

Place of the transaction

 

XLON

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBXGDLDGDDGUR
Date   Source Headline
26th Jun 20153:42 pmRNSDirector/PDMR Shareholding
22nd Jun 20157:00 amRNSAcquisition
16th Jun 201510:24 amRNSAnnual Financial Report
4th Jun 20151:55 pmRNSNet Asset Value(s)
27th May 20157:00 amRNSFinal Results
11th May 20152:38 pmRNSHolding(s) in Company
11th May 20159:22 amRNSNet Asset Value(s)
30th Apr 201510:30 amRNSDirector Declaration
17th Apr 20153:51 pmRNSHolding(s) in Company
16th Apr 20154:10 pmRNSHolding(s) in Company
15th Apr 20159:15 amRNSHolding(s) in Company
14th Apr 20152:47 pmRNSHolding(s) in Company
14th Apr 20159:38 amRNSDirector Declaration
10th Apr 201512:30 pmRNSHolding(s) in Company
10th Apr 20159:12 amRNSNet Asset Value(s)
1st Apr 20152:58 pmRNSHolding(s) in Company
31st Mar 20154:44 pmRNSTransaction in Own Shares
25th Mar 20151:12 pmRNSDirector/PDMR Shareholding
20th Mar 20152:15 pmRNSHolding(s) in Company
18th Mar 20157:06 amRNSDirector Declaration
18th Mar 20157:00 amRNSDirectorate Change
9th Mar 20154:30 pmRNSSignificant holding in Company
9th Mar 20159:14 amRNSNet Asset Value(s)
9th Mar 20157:00 amRNSHolding(s) in Company
3rd Mar 201510:39 amRNSHolding(s) in Company
27th Feb 20155:28 pmRNSHolding(s) in Company
19th Feb 20152:17 pmRNSHolding(s) in Company
5th Feb 20152:31 pmRNSNet Asset Value(s)
26th Jan 201510:52 amRNSHolding(s) in Company
16th Jan 20154:30 pmRNSHolding(s) in Company
12th Jan 201510:45 amRNSHolding(s) in Company
8th Jan 201510:35 amRNSInterim Management Statement
8th Jan 201510:31 amRNSNet Asset Value(s)
2nd Jan 20157:00 amRNSBlocklisting Interim Review
18th Dec 20149:45 amRNSDirector/PDMR Shareholding
5th Dec 201410:44 amRNSNet Asset Value(s)
1st Dec 20144:40 pmRNSHolding(s) in Company
28th Nov 20149:19 amRNSDirector/PDMR Shareholding
25th Nov 201412:37 pmRNSHolding(s) in Company
25th Nov 20147:00 amRNSHalf Yearly Report
10th Nov 20149:22 amRNSNet Asset Value(s)
7th Oct 20143:20 pmRNSNet Asset Value(s)
30th Sep 20144:47 pmRNSTransaction in Own Shares
30th Sep 20144:42 pmRNSTotal Voting Rights
25th Sep 20145:10 pmRNSHolding(s) in Company
15th Sep 20145:08 pmRNSTransaction in Own Shares
5th Sep 20148:15 amRNSNet Asset Value(s)
1st Sep 20148:43 amRNSHolding(s) in Company
22nd Aug 20143:24 pmRNSHolding(s) in Company
18th Aug 20143:14 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.